This mirrors findings in syngeneic melanoma models where Igf2bp1 knockdown enhanced ICT responsiveness.27 scRNA-seq analysis revealed that BT boosts immune infiltration and reactivation beyond that achieved by PD-1 blockade alone. This evidence concerns the gene IGF2BP1 and melanoma.